"Palatin concludes Phase II trial of combination therapy for obesity" was originally created and published by Clinical Trials ...

During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...

Amgen (AMGN) provided updates on selected product and pipeline programs, including that a Phase 1 study of AMG 513 in people living with ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Faculty of Chemistry, University of Gdańsk, Fahrenheit Union of Universities, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland ...

Barclays (LON:BARC) initiated coverage on PolyPeptide Group AG (SIX:PPGN:SW) stock with an Overweight rating and a price target of CHF 40.00. The firm anticipates a return to positive EBITDA for ...

This theory supposes the uncoiling of a polypeptide chain (see, for example, Astbury and Lomax 1); but so far direct evidence in support of it has been meager and confused by experimental results ...

Given that more than 100 million US adults have obesity, including 22 million with severe obesity, physicians regularly see patients with the condition in their practices. Fortunately, doctors ...

THE amphoteric ionic behaviour, one of the characteristics of proteins, has been considered to be due to the presence of the amino- and the carboxyl-groups in the side-chains of the polypeptide chain.